Optimal scheduling to reduce morbidity of involved field radiotherapy with transplantation for lymphomas: A Prospective Australasian Leukaemia and Lymphoma Group Study

@article{Wirth2005OptimalST,
  title={Optimal scheduling to reduce morbidity of involved field radiotherapy with transplantation for lymphomas: A Prospective Australasian Leukaemia and Lymphoma Group Study},
  author={Andrew Wirth and H Miles Prince and Martin Wolf and Janey Malka Stone and J Matthews and John O Gibson and Craig Macleod and Jeffrey Szer and Amanda J. Grigg and Bik L. To and Daniel R Roos and Anthony P. Schwarer and Sallie Jenkins Davis},
  journal={Bone Marrow Transplantation},
  year={2005},
  volume={35},
  pages={291-298}
}
Summary:This study evaluated delivery of involved field radiotherapy (IFRT) with transplantation for lymphomas timed to minimise toxicity. Patients transplanted for lymphoma had infradiaphragmatic disease irradiated pre-transplant and supradiaphragmatic disease post transplant. A total of 31 patients were studied, with a median follow-up duration of 4 years. Transplant conditioning was according to clinician preference. In all, 14 patients had pre-transplant abdominopelvic IFRT and 19 had post… CONTINUE READING
BETA

References

Publications referenced by this paper.
SHOWING 1-10 OF 54 REFERENCES

Radiation therapy as a component of high-dose salvage strategies in Hodgkin's disease.

  • Annals of oncology : official journal of the European Society for Medical Oncology
  • 1998
VIEW 2 EXCERPTS
HIGHLY INFLUENTIAL

Randomized study to evaluate the use of high-dose therapy as part of primary treatment for "aggressive" lymphoma.

  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2002

Should involvedfield radiation therapy be used as an adjunct to lymphoma autotransplantation ?

AJ Mundt, G Sibley, S Williams
  • Bone Marrow Transplant
  • 2002

external beam radiation therapy prior to autologous bone marrow transplantation in patients with non-Hodgkin’s lymphoma

CH Weaver, FR Appelbaum, FB Petersen
  • Biol Blood Marrow Transplant
  • 2001

transplantation for diffuse aggressive non-Hodgkin’s lymphoma in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry

JW Friedberg, D Neuberg, E Monson
  • J Clin Oncol
  • 2001

Similar Papers

Loading similar papers…